1 Paediatric And Adolescent Diabetes Care Dr Noman Ahmad 3 rd February 2011 Cork University Hospital.

Slides:



Advertisements
Similar presentations
Insulin Therapy. Insulin Treatment (when?) Any Glucose Level Age Rapid onset Weight loss Tablets fail Pregnancy Illness Ketoacidosis Pancreat-ectomy.
Advertisements

DIABETES MELLTIUS Dr. Ayisha Qureshi Assistant Professor MBBS, MPhil.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
1 Diagnosis of Type 1 Diabetes. 2 Classifying Diabetes IAA, autoantibodies to insulin; GADA, glutamic acid decarboxylase; IA-2A, the tyrosine phosphatase.
Pancreas & diabetes Željka Kušter Mentor: A. Žmegač Horvat.
Islets of Langerhan. Prof. K. Sivapalan Islets of Langerhan2 Histology. A cells 20 % [glucogon] B cells 50% [Insulin] D cells 8% [somatostatin]
Diabetes Mellitus.
Insulin initiation OPTIMISING Glycaemic control and Weight Dr C Rajeswaran Consultant Physician Diabetes & Endocrinology Mid Yorkshire NHS Trust.
Control of Blood Sugar Diabetes Mellitus. Maintaining Glucose Homeostasis Goal is to maintain blood sugar levels between ~ 70 and 110 mg/dL Two hormones.
Diabetes mellitus Dr. Essam H. Jiffri.
Type 1 Diabetes Debbie McCausland Paediatric Diabetes Specialist Nurses.
Concepts in the natural history of diabetes.
Insulin therapy.
Diabetes Mellitus Type 1 By Sheryl Heichel. What is Type 1 Diabetes?  Type 1 diabetes, also referred to as juvenile diabetes, is a disease in which the.
Paediatric Endocrine Disorders F Thyroid disorders F Childhood diabetes mellitus F Pubertal disorders - early/late F Pituitary disorders - hypopituitarism.
Type 2 DM Etiology – The pancreas cannot produce enough insulin for body ’ s needs – Impaired insulin secretion.
Drugs used in Diabetes Dr Sally Hudson. BIGUANIDES reduce output of glucose from the liver and enhances uptake and use of glucose by muscle cells ExampleADVANTAGESDISADVANTAGESCOSTCaution.
Adult Medical-Surgical Nursing
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Diabetes Mellitus Type 1
DIABETES Paediatrics and Adolesence Dr Aisling Myers Clinical Lecturer.
DIABETES MELLITUS PATHOGENESIS, CLASSIFICATION, DIAGNOSIS.
INSULIN THERAPY IN TYPE 1 DIABETES
Chapter 24 Chapter 24 Exercise Management.  Diabetes is a chronic metabolic disease characterized by an absolute or relative deficiency of insulin that.
Are You A Candidate For An Insulin Pump?
Insulin in Primary Care Dr Saqib Mahmud, MRCP(UK), MRCGP.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Endocrine Disorders in the Pediatric Client Susan Beggs, MSN, CPN Susan Beggs, MSN, CPN.
Adult Medical-Surgical Nursing Endocrine Module: Acute Complications of Diabetes Mellitus.
DIABETES MELLITUS THOMAS MILLIGAN, DO OSU-COM FAMILY MEDICINE.
دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد INSULIN THERAY IN TYPE 1 DIABETES.
Dr. Hany Ahmed Assistant Professor of Physiology (MD, PhD) Al Maarefa Colleges (KSA) & Zagazig University (EGY) Specialist of Diabetes, Metabolism and.
Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.
Type I Diabetes Mellitus
TALK DIABETES November 13, 2015 Pumping Insulin 101 Bonnie Stone-Hope RN, CDE, BA.
Dr. Nathasha Luke.  Define the term glucose homeostasis  Describe how blood glucose levels are maintained in the fasting state and fed state  Describe.
 Provide a high level overview of diabetes head to toe.  Discuss the importance of keeping A1Cs under 8.  Identify ways to prevent long-term complications.
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.
Diabetes Mellitus Aaqid Akram MBChB (2013) Clinical Education Fellow.
Diabetes Mellitus: Prevention & Treatment Medical surgical in nursing /02/01.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
Diabetes Mellitus Classification & Pathophysiology.
"We can be very successful at controlling diabetes."
Diabetic Profile Measurement of Blood Glucose T.A. Bahiya Osrah.
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Last modified January 2015.
Diabetes mellitus.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS.
Carbohydrates: Clinical applications Carbohydrate metabolism disorders include: Hyperglycemia: increased blood glucose Hypoglycemia: decreased blood glucose.
Hyperglycaemias, hypoglycaemias Erhardt Éva MD, PhD.
Understanding Diabetes Mellitus Opara A.C. MB;BS, FWACS.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Diabetes mellitus.
Alisa Foote SDSU School of Nursing 10/14/11.
Interventions for Clients with Diabetes Mellitus
Diabetes Mellitus.
Diabetes Mellitus.
Endocrine System KNH 411.
Endocrine System KNH 411.
Diabetes.
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Presentation transcript:

1 Paediatric And Adolescent Diabetes Care Dr Noman Ahmad 3 rd February 2011 Cork University Hospital

2 Presentation Outline Definition Classification Pathophysiology Clinical Presentation Insulin types and regimens Insulin dose in different age groups Follow-up/Monitoring

3 Learning Objectives Understanding of insulin pharmacokinetics Right insulin regimen Aims of glycaemic control Complexity of management in different age groups

4 Definition Diabetes mellitus is group of metabolic diseases characterised by chronic hyperglycaemia resulting from defects in insulin secretion, action or both International society of paediatric and adolescent diabetes

5 Insulin Physiology

6 Classification Type 1 diabetes (IDDM) Type 2 diabetes (NIDDM) Monogenic diabetes (MODY) Neonatal diabetes (Transient first 3 months) Mitochondrial diabetes Cystic fibrosis related diabetes (CFRD) Drug induced hyperglycaemia

7 Pathophysiology T1DM Autoimmune destruction (T1A DM) Non autoimmune destruction (T1B DM) Multiple genes HLA genes (DR, DQ alpha, DQ beta) Autoantigen (Islet cells, Insulin, glutamic acid decarboxylase GAD 65, Isulinoma associated protien 2 IA-2, Zinc transporte ZnT8

8 Pathophysiology T1DM Environmental factors Viruses (Entero, Coxsackie, EBV) Cow’s milk Perinatal factors Vitamin D

9 Pathophysiology T1DM Association with other autoimmune diseases Thyroid 20% Adrenal 1.7% Coeliac disease 10% Polyglandular autoimmune disease

10 Pathophysiology T1DM Genetic predisposition HLA associations Environment Viruses, toxins, cow’s milk Immune dysregulation GAD 65, IA-2,Insulin, ZnT8,Islet cells Beta islet cell destruction Insulin deficiency Type 1 diabetes

11 Pathophysiology of T2DM

12 Presentation of T1DM Classic (most common)  Polyuria, polydipsia and weight loss Diabetic ketoacidosis  Hyperglycaemia, metabolic acidosis and ketonuria Silent  Usually siblings of known cases

13 Presentation of T2DM Girls 1.7 times more common Obesity, signs of insulin resistance (acanthosis nigricans) Strong family history, LBW, gestational diabetes Insulin resistant states (puberty, PCOS) Impaired OGTT Elevated A1C DKA Hyperosmolar coma with no ketunuria

14 Acanthosis Nigricans

15 INSULIN TYPES Short acting Regular Analogs (Novorapid,Humolog,Apidra) Intermediate acting NPH Long acting Detemir (Levemir) Glargine (Lantus)

16 Pharmacokinetics

17 Pharmacokinetics

18 Insulin Regimens Conventional  Premixed (Mixtard 30, Novomix 30)  Short acting(Novorapid) and intermediate acting (NPH) Intensive  MDI (Lantus or Levemir and Novorapid)  Insulin pump (CSII)

19 Insulin Regimens Conventional  Positives Twice a day No carbohydrate counting Good for new patients and school going kids Less chance of DKA  Negatives Non physiological Less flexible More risk of hypoglycaemia Loose glycaemic control

20 Conventional Regimen Novorapid Insultard (NPH)

21 Insulin Regimen (MDI)

22 Insulin Regimen (MDI) Intensive  Positive Physiological Flexible Less risk of hypoglycaemia Good for teenagers Less long term side effects Better glyceamic control  Negatives More injections Carbohydrate counting More risk of DKA

23 Insulin Pump Continuous basal infusion Bolus with every meal or snack Correction bolus Regular or rapid insulin

24 Insulin Pump

25 Insulin Pump

26 Insulin Pump Advantages  Flexible  Precise  Better glycaemic control  Less variability  Less Hypoglycemia  Less long term complication

27 Insulin Pump Disadvantage  Tethered with device  Cost  Infection  Equipment failure  Carbohydrate counting  DKA  Hinder in some activities

28 Injection Sites Fast absorption in abdomen Slow in legs Intermediate in arms Subcutaneous fat Skin very slow absorption Muscles too fast

29 High Insulin Doses Growth Puberty Sickness Stress Active/competitive sports Steroid therapy No physical activity

30 Target Blood Glucose Preprandial  CDA years years4-10 >12 years4-7  ISPAD for all kids 2 hours postprandial 5-10 for all kids

31 Target HbA1C CDA 2008  <6 years8.5%  6-12< 8%  >12 years≤ 7% ISPAD 2009  < 7.5% for all kids

32 Clinic Visit History  Glucose diary  Hypoglycaemia  Intercurrent illness  Thyroid, adrenal, coeliac  Exercise  Hypoglycaemia supplies

33 Clinic Visit Examination  Growth, weight, BP  Thyroid  Injection sites  Finger poke sites  Pubertal exam  Retinal exam  Prayer signs

34 Clinic Visit Investigations  HbA1C every 3 months  TSH annually  Coeliac screen  Lipid profile  Albumin creatinine ratio  Eye exam

35 Infants And Toddlers Brain is very sensitive to hypoglycaemia Sensitive to Regular/rapid insulin Picky eater May need to give insulin after meals

36 Adolescents Insulin resistance Non compliance Fabrication Denial Eating out and snacking Family conflicts Alcohol Eating disorders

37 QUESTIONS